DV
Dividend Vision

NBIX — Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc. (NBIX)

Total return is 1121.8% over the past 30.2 years, 705.5 points behind SPY at 1827.3%. Its deepest 1-year drawdown was 20.9%.

NBIX is an individual equity stock in the biotechnology sector, not an ETF. As a single-stock holding rather than a diversified fund, it does not have the typical ETF characteristics such as expense ratios, distribution frequencies, or stated fund objectives. The company does not currently pay dividends, making it unsuitable for income-focused investors seeking regular distributions.

NBIX key facts

Asset type
Stock
Asset class
Equity
Inception date
05/23/1996
Distribution frequency
None
Last close
$152.72
Market cap
$15,523,863,552
Average volume
1305100.0
Ex-dividend date
12/29/1995
Beta
0.394
Payout ratio
0.0
P/E ratio
22.2949
Forward P/E
24.3309
EPS
$6.85